Hyperpolarizing Phosphates to Diagnose Disease: a Hadassah World First

Wednesday, Aug 30 2017

What can the phosphorus in your blood tell you about your health?

Researchers in the Hadassah Medical Organization’s imaging department have developed a world-first noninvasive diagnostic method to measure phosphate levels in the body’s tissues that can alert them to the presence of diseases such as cancer.

Their discovery appears in the August 24, 2017 online issue of Nature Communications.

The novel procedure is being hailed as a breakthrough because it is currently impossible to test the acidity level in the tissues of the human body without performing an invasive procedure. In addition, examining a tissue sample for this purpose is not a diagnostic option because body tissue changes within seconds. With this new diagnostic tool, however, researchers can determine the level of acidity which can vary, for example, when there is a cancerous tumor present.

Dr. Rachel Katz-Brull, who heads Hadassah’s research team, explains: “This is a diagnostic tool related to the metabolic function of the cells in a tumor or other suspicious tissue. Such a measure could allow, for example, a more precise identification of a tumor as malignant or benign and help test the efficacy of treatment.”

With this new technology, a patient could be saved from invasive procedures such as a biopsy to determine whether a tumor is cancerous. Instead, via this high-tech MRI imaging, the phosphate is caused to “shine” more than 10,000 times brighter, enabling the researchers to see the nucleus of the phosphorous-containing cell. And this clarity is achieved without injecting radioactive materials into the patient. Hadassah is one of the few medical centers in the world that is equipped with this technology.

Dr. Katz-Brull completed postdoctoral research at Harvard University and Beth Israel-Deaconess Hospital in Massachusetts. When she returned to Israel, she established the Center for Hyperpolarized MRI Molecular Imaging in Hadassah’s radiology department.

Read more in the Jerusalem Post.

Related Stories

alt_text

Tuesday, Jan 12 2021

Hadassah Speedily Vaccinates Its Staff Against COVID-19

As of January 11, out of the 6,500 individuals who work at the Hadassah Medical Organization, 4,800 had received their first dose of the Pfizer vaccine, and 1,000 had received the second dose.

READ MORE ›
alt_text

Tuesday, Jan 5 2021

Mary, From Bethlehem, Experiences Personal Christmas Miracle at Hadassah

Christmas Eve is always a special time for Mary A, an 86-year-old resident of Bethlehem.

READ MORE ›
alt_text

Tuesday, Dec 29 2020

Nurses Inject Hope at Hadassah Hospital Ein Kerem

The sun has just come up. It is 6 am and 18 pairs of eyes are staring at two Hadassah Hospital Ein Kerem nurses. One nurse is seated and the other is standing over her, a needle in hand.

READ MORE ›
alt_text

Monday, Dec 21 2020

What Are Organoids? Welcome to a Revolution in Basic Medical Science

Classically, researchers in basic medical science have had two tools: in vitro cultures and animal models. The challenges posed by their limitations are many.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More